ibrutinib
janssen,abbvie
[]
re: #17icml comment about aes on placebo arm. this is why we need patient-reported outcomes &amp; formal assessment of patient-reported tolerability! investigators consistently underestimate symptoms; this has been empirically shown by &amp; others: 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈